FDA Inspection
BloodworksBloodworks – FDA Inspection, Mar 22, 2019
Record Details
This FDA Inspection record concerns Bloodworks, with an inspection on March 22, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · e6268635-23bc-4f98-95f6-349223d3207f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1085290
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bloodworks
7| Date | Classification | Office | Project area |
|---|---|---|---|
| October 26, 2023 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 17, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 4, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 3, 2014 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 6, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Bloodworks
- FDA Inspection 1223141 - 2023-10-26
- FDA Inspection 1002630 - 2017-02-17
- FDA Inspection 913090 - 2015-02-04
- FDA Inspection 886230 - 2014-07-03
- FDA Inspection 790518 - 2012-07-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.